19-43592722-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001007561.3(IRGQ):āc.1176G>Cā(p.Glu392Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,610,812 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001007561.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRGQ | ENST00000422989.6 | c.1176G>C | p.Glu392Asp | missense_variant | 3/3 | 5 | NM_001007561.3 | ENSP00000387535.1 | ||
IRGQ | ENST00000602269.2 | c.1176G>C | p.Glu392Asp | missense_variant | 2/2 | 1 | ENSP00000472250.1 | |||
ENSG00000268361 | ENST00000594374.1 | c.168+146G>C | intron_variant | 3 | ENSP00000472698.1 | |||||
IRGQ | ENST00000601520.1 | n.251+35G>C | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152228Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1458584Hom.: 0 Cov.: 32 AF XY: 0.00000276 AC XY: 2AN XY: 725788
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152228Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.1176G>C (p.E392D) alteration is located in exon 3 (coding exon 2) of the IRGQ gene. This alteration results from a G to C substitution at nucleotide position 1176, causing the glutamic acid (E) at amino acid position 392 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at